$USCB

Collazo of USCB Financial sells $146k in shares

Andres Collazo, EVP of Operations & IT at USCB Financial Holdings, sold 8,000 shares of Class A Voting Common Stock for a total of $146,160 on March 7, 2026. Prior to this, he exercised options to acquire 8,000 shares and later disposed of 429 shares. These transactions leave Collazo with 32,521 directly owned shares and options for an additional 30,000 shares.

Original reporting
Investing.com India · Investing.com
Published Mar 11, 2026, 10:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 11, 2026, 11:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$USCB
Bearish
medium confidence
Mentioned
$USCB
Relevance
6/10
AlphAI data visualization · based on Investing.com India
Decision brief

The 30-second read

$USCBBearishLow
01

Why it matters

The insider sale indicates a potential shift in insider confidence or liquidity needs. While such sales can be routine, they may influence investor sentiment, especially if perceived as a lack of confidence in the company's near-term prospects.

02

Market read

The insider transaction has limited direct impact but could influence short-term sentiment in the regional banking sector.

03

What to watch

The company's overall financial health and recent earnings reports should be considered before making trading decisions.

Relevance 6/10Timing: short-term

Background

Andres Collazo, EVP of Operations & IT at USCB Financial Holdings, sold 8,000 shares of Class A Voting Common Stock for a total of $146,160 on March 7, 2026. Prior to this, he exercised options to acquire 8,000 shares and later disposed of 429 shares. These transactions leave Collazo with 32,521 directly owned shares and options for an additional 30,000 shares.

Company-level read

Ticker impact

$USCBBearishMedium confidence
Context

Insider trading activity by a senior executive

Expected impact

Moderate short-term decline expected due to bearish sentiment from insider activity.

Evidence & confidence

Insider sales can sometimes signal lack of confidence, but may also be routine. The recent sale, combined with the somewhat-bearish sentiment score, suggests cautious outlook.

Market effects

Financial sector may experience slight negative bias due to insider sales in a regional bank.

Limited regional impact; primarily affecting USCB's local market perception.

Minimal global relevance as the event pertains to a regional financial institution.

Counterpoint

Insider sales are routine and may not indicate negative outlook; could be for personal liquidity or diversification.

Key entities

  • USCB Financial Holdings

    A regional financial services company.

  • Andres Collazo

    EVP of Operations & IT at USCB Financial.

Related articles

$USCBMed

USCB Financial Holdings, Inc. Surpasses $3 Billion in Assets with 14.6% Annualized Linked-Quarter Loan Growth; Achieves Q2 2026 EPS of $0.49, 3.49% Net…

USCB FINANCIAL HOLDINGS, INC. (USCB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 5 exhibit991.htm EX-99.1 exhibit991 1 Exhibit 99.1 EARNINGS RELEASE USCB Financial Holdings, Inc. Surpasses $3 Billion in Assets with 14.6% Annualized Linked-Quarter Loan Growth; Achieves Q2 2026 EPS of $0.49, 3.49% Net Interest Margin, ROAA of 1.26%, and ROAE of 15.90% M

$NFLXMed

Netflix film chief Dan Lin to leave amid growth concerns

Netflix film chief Dan Lin is leaving after nearly three years, following Bela Bajaria's departure. Peter Rice will temporarily lead the film division. The changes come amid growth concerns and competition. Netflix co-CEO Ted Sarandos acknowledged slower-than-desired growth. The company is also cutting 6% of its workforce and will report Q3 results on Tuesday.

$CEGMed

Is This Number The Biggest Risk To Constellation Energy Stock?

Constellation Energy (CEG) reported $24.7B in debt as of June 2026, up from $8.3B a year prior. Its stock fell 32.4% over the past year, underperforming the S&P 500. The company's debt is 25.3% of its market value, slightly above the S&P 500's 20.0%. Free cash flow was negative in the last three quarters, but cash from operations rose to $4.2B in the year to June 2026. Management expects $5.9B from asset sales related to the Calpine acquisition.

$CURXLow

Curanex Pharmaceuticals Inc (CURX): Daymond Morales, et al., filed a putative securities class action in the Supreme Court of the State of New York, New York County (Index No. 159271/2026)…

Curanex Pharmaceuticals Inc (CURX) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. Legal Proceedings On July 23, 2026, Daymond Morales, et al., filed a putative securities class action in the Supreme Court of the State of New York, New York County (Index No. 159271/2026), against the Company and its underwriters Dominari Securities LLC,